
|Articles|April 1, 2003
Technology in trials: Early results promising for presbyopia reversal
Orlando-Early results from a clinical trial for the reversal and treatment of presbyopia, using SurgiLight Inc.'s OptiVision technology, appear "promising," according to researchers at New York-Presbyterian Hospital Weill Cornell Medical Center.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
3
IRIS Registry data mined for understanding of pediatric NK
4
International meta-analysis highlights elevated ocular risk in Clade I Monkeypox
5












































